Xcel Brands to Report First Quarter 2020 Financial Results on May 19, 2020
NEW YORK, May 15, 2020 (GLOBE NEWSWIRE) — Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), a brand management […]
Zogenix Launches Shine Forward with Dravet, a New Source of Inspiring Ideas for Parents of Children Living with Dravet Syndrome
EMERYVILLE, Calif., May 15, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, […]
Mersana Therapeutics to Present Two Posters at the American Association for Cancer Research 2020 Virtual Annual Meeting
CAMBRIDGE, Mass., May 15, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and […]
Sysco to Webcast Presentation of the 2020 Bernstein Strategic Decisions Conference
HOUSTON, May 15, 2020 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) today announced that the Company will webcast its presentation of […]
TSX News -
Dream Unlimited Corp. Provides Supplemental Earnings Information
TORONTO, May 15, 2020 (GLOBE NEWSWIRE) — Dream Unlimited Corp. (TSX: DRM) (“Dream”, “the Company” or “we”) today announced supplemental […]
BlackRock® Canada Announces May Cash Distributions for the iShares® ETFs
TORONTO, May 15, 2020 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, […]
TORM plc Long-Term Incentive Program
In accordance with TORM plc’s (“TORM”) Remuneration Policy adopted by the Annual General Meeting of TORM plc on 12 April […]
Orgenesis Announces Stock Repurchase Plan of Up to $10 Million
GERMANTOWN, Md., May 15, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech […]
Surface Oncology to Present Preclinical Data for Multiple Product Programs at the American Association for Cancer Research Annual Meeting
CAMBRIDGE, Mass., May 15, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target […]
ContraFect Reports First Quarter 2020 Financial Results and Provides Business Update
YONKERS, N.Y., May 15, 2020 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
